Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Renal Transplant Outcome Prediction and Validation Study (TOPVAS)

NCT03978065 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT03978065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03978065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Renal Transplant Outcome Prediction and Validation Study (TOPVAS)
Lead sponsor
Medical University Innsbruck
Phase
Not applicable
Overall status
Unknown status
Start date
June 11, 2015
Completion date
March 31, 2020
Enrollment
113 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ischemia reperfusion injury